you are here: HomeNewsBusiness

Coronavirus pandemic | Blue Star sees no disruption to supply chain in short term

Thiagarajan said the company is targeting to increase its market share to 15 per cent by FY24 in the domestic air conditioner segment from the present 12.5 per cent.

March 13, 2020 / 08:11 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Air conditioner manufacturer Blue Star on Friday said the coronavirus outbreak is unlikely to have any impact on its supply chain in the short run as it has already stocked up on components. The company also said it looking to increase its market share to 15 per cent in the next 4-5 years from 12.5 per cent currently.

"In December 2019, we had increased the quantities of components ahead of the Budget in February. It fortunately will help us to carry on till March-end. However, we will have a window where I will run out of components between April 15 and 30, but since the demand (also will come down), I am not so much worried," the company's Managing Director B Thiagarajan told reporters here.

He said in the summers, the industry sees 20-25 per cent growth in sales of ACs but is likely to witness a 5-10 per cent correction in demand this year due to economic uncertainty amid the virus pandemic.

Thiagarajan said the company is targeting to increase its market share to 15 per cent by FY24 in the domestic air conditioner segment from the present 12.5 per cent.

"Currently we enjoy 12.5 per cent market share in the residential air conditioners (segment) and are expecting to close this financial year with 12.75 per cent. In FY21 our target is 13 per cent market share and in FY24 we are targeting 15 per cent," he said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Talking about price hikes, he said in February Blue Star had increased prices by 3-5 per cent due to rise in input cost and also as ocean freight went up by 65 per cent, the company had to airlift some components.

The company on Friday launched a new range of residential air conditioners.

The 3-star inverter split air conditioners are available at a starting price of Rs 31,990.
PTI
first published: Mar 13, 2020 08:00 pm

stay updated

Get Daily News on your Browser
Sections